Dr. Roth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 NJ-70 W
Suite 600
Lakewood, NJ 08701Phone+1 732-363-2396Fax+1 732-363-0403
Summary
- Dr. Daniel Roth is an ophthalmologist based in Lakewood, NJ, with subspecialties in vitreoretinal surgery and retinal disease and uveitis. He completed his medical education at Yale School of Medicine in 1994, followed by an ophthalmology residency at the University of Miami/Jackson Health System/Bascom Palmer Eye Institute, and a fellowship in surgical retina and vitreous at the Cleveland Clinic Foundation. Since 2000, he has been a partner at NJ Retina, part of the Prism Vision Group. His expertise lies in AMD, retinal vascular disease, macular edema, retina surgery, vitreoretinal disease, and pediatric retinal disease. Dr. Roth has published multiple articles, including research on diabetic macular edema and endophthalmitis. He has been involved in numerous clinical trials, published over 90 peer reviewed manuscripts and has received accolades from institutions such as Castle Connolly and NJ Top Doctors. He is also a member of professional organizations like the Macula Society and the Retina Society.
Education & Training
- Cleveland Clinic FoundationFellowship, Surgical Retina and Vitreous, 1998 - 2000
- University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1995 - 1998
- University of TennesseeInternship, Internal Medicine, 1994 - 1995
- Yale School of MedicineClass of 1994
Certifications & Licensure
- NJ State Medical License 2000 - 2025
- OH State Medical License 1998 - 2002
- FL State Medical License 1996 - 2000
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- • Top Doctors Castle Connoly
- Best Doctors in America Best Doctors
- NJ Top Doctor NJ Top Doctors
- Join now to see all
Clinical Trials
- Antenatal Vitamin D3 Supplementation in Bangladesh: Randomized Controlled Trial Start of enrollment: 2010 Aug 01
- Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients. Start of enrollment: 2013 Dec 01
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 2 citationsThe 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 Months.Daniel B Roth, David Eichenbaum, Deepika Malik, Nathan M Radcliffe, Antonio Cutino
Ophthalmology. Retina. 2024-01-01 - Corrigendum to "The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema" [Am J Ophthalmol 2023;248;16-23].Pauline T Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian
American Journal of Ophthalmology. 2023-08-01 - 4 citationsThe 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema.Pauline T Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian
American Journal of Ophthalmology. 2023-04-01
Press Mentions
- Prism Vision Group’s Physicians Reviewed and Approved as NJ Top Docs for 2021June 3rd, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: